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Equine herpesvirus-1 (EHV-1) latency in murine olfactory bulbs was demonstrated by a novel combined in situ PCR and
in vitro protein synthesis method (in situ PS –PCR). The Escherichia coli lacZ gene replacing a deletion in EHV-1 gene 71
(EUS4) was thus amplified and transcribed/translated in situ followed by enzymatic detection using X-Gal (5-bromo-4-chloro-
3-indoyl-b-D-galactopyranoside). b-Galactosidase was found to be concentrated over mitral/tufted neurons indicating those
to be the sites of latency. Our results suggest that, in common with other a-herpesviruses, EHV-1 can establish latency in
central nervous system neurons and that the unique membrane glycoprotein encoded by EHV-1 gene 71 is nonessential
for infection of neural tissues. q 1997 Academic Press
Latent infection of neurons is central to the life-cycle In situ PCR provides a more sensitive method of de-
tecting low copy viral genomes and has now been widelyof most Alphaherpesvirinae and has been demonstrated
for many both in their natural host and in laboratory ani- reported in the literature (15, 16, 22, 23, 26, 31) We de-
mal models (7, 9 – 14, 17, 19, 21, 27, 28, 32). Equine her- scribe here a modification of the method which combines
pesvirus-1 (EHV-1), which has long been regarded an in situ DNA PCR with in vitro protein synthesis (in situ
anomaly in this respect, has recently been amplified by PS– PCR) allowing the de novo synthesis of polypeptide
a nested polymerase chain reaction (nPCR) from both or whole protein from PCR-generated templates ampli-
latently infected equine and murine trigeminal ganglia fied from virus sequences within latently infected tissue
and olfactory bulbs and, in the horse, has also been sections. Detection of the newly synthesized protein is
reactivated from latent infection in the trigeminal ganglia then made by addition of labeled monoclonal antibody.
(5, 29). Moreover, trigeminal neurons have been unequiv- Because only correctly amplified template DNAs can ulti-
ocally identified as a site of EHV-1 latency in the horse mately yield the correct polypeptide for which the mono-
by both in situ DNA and RNA hybridization (6). clonal antibody has affinity, the method is highly specific.
In a well-characterized murine model for EHV-1 infec- In this work we have used in situ PS– PCR to selec-
tion (1 – 5, 8, 18, 24, 25), virus was recovered from the tively amplify and transcribe/translate the entire Esche-
olfactory bulbs during primary infection following intrana- richia coli lacZ gene from tissue sections latently infected
sal (i.n.) instillation of virus and mitral/tufted neurons with a b-galactosidase-positive EHV-1 mutant, ED71 (33).
were found to be the cellular site of infection (unpub- We use the method to show for the first time that EHV-
lished observations and Fig. 2A). Efforts to study EHV-1 1 establishes a latent infection in mitral/tufted neurons
latency in the BALB/c mouse, however, have been ham- within the olfactory bulbs of BALB/c mice following i.n.
pered by an inability to reactivate either wild-type or lacZ infection.
recombinant viruses from neural tissues by either ex- ED71 has an SV40 early promoter-driven lacZ cassette
plant/cocultivation or corticosteroid administration and replacing a deletion in the nonessential EHV-1 gene 71
by the fact that b-galactosidase is no longer expressed (EUS4) ORF encoding a membrane glycoprotein unique
from the simian virus 40 (SV40) promoter during latency to EHV (34). The lacZ-based procedure employed in this
(unpublished observations). Moreover, the levels of EHV- work demonstrates that even relatively large proteins
1 latency-associated transcription in the mouse have such as b-galactosidase may be synthesized in situ.
been found to be below the level of sensitivity of in situ Moreover, enzymatic detection of the b-galactosidase
RNA hybridization (5). molecules by addition of the chromogenic substrate X-
Gal increases further the specificity because only func-
tional b-galactosidase molecules may catalyze the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 1223 332998. E-mail: hjf10@cam.ac.uk. reaction.
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In situ PS– PCR bridges in situ PCR with in vitro protein
synthesis via PCR primers incorporating the T7 RNA poly-
merase promoter and a ribosome binding site (20) which
allow for subsequent transcription/translation of the PCR-
generated templates. The E. coli S-30 extract linear DNA
transcription/translation system (Promega Corp., Madi-
son, WV) was selected to produce the protein molecules
because a prokaryotic protein synthesis system was ex-
pected to minimize binding of RNA polymerase and ribo-
somes to extraneous promoters present in the tissue
sections, thereby enhancing sensitivity.
The method was applied to sections of ED71-infected
olfactory bulb obtained from mice 2 months after i.n. in-
fection with 1 1 107 plaque-forming units (PFU) per FIG. 1. The general structure of the EHV-1 genome is given in A.
mouse. Sections for in situ PCR were prepared as pre- The genome segments indicated are: UL , unique long; US, unique short;
IRS, short internal repeat; TRS , short terminal repeat. Also shown is theviously described (22) with some modifications. Tissues
BamHI ‘‘D’’ fragment showing the positions and orientations of ORFs inwere placed in 10% formalin overnight followed by dehy-
the US genome segment. ORFs, represented by arrows, are numbereddration in 70% ethanol for 24 hr. Following paraffin-em- according to the nomenclature of Telford et al. (35). A double-stranded
bedding, 5-mm sections were cut and placed onto 3- detail of the gene 71 ORF in the mutant ED71 is given in B showing
aminopropyl-triethoxysilane (APES)-coated microscope the presence of the SV40-driven lacZ cassette. Also indicated in B are
the positions at which primers P1, P2, and P3 bind to gene 71 se-slides. The paraffin wax was removed by two 10-min
quences flanking the lacZ cassette. The sequences of primers P1, P2,incubations in xylene at room temperature followed by
and P3 are given in C. EHV-1-specific sequences are underlined. Theimmersion in 100% ethanol for 5 min at room tempera- ribosome binding site (RBS) and T7 promoter (pT7) sequences present
ture. The sections were washed thoroughly in distilled in primer P3 were taken from those previously published by (Lesley et
water and then proteinase K (10 mg/ml) was added for al. (20)). Not drawn to scale.
40 min at 557. Sections were immersed in a 0.01% Triton
X-100 solution and incubated at room temperature for 10
min followed by three 5-min washes in distilled water. dard 1-mm-thick microscope slide. The PCR mix con-
sisted of 200 mM of each dNTP, 4 mM MgCl2 , 10 mMThey were then incubated at 1007 for 5 min, refixed in
2% paraformaldehyde overnight, and then washed thor- Tris – HCl (pH 9.0), 50 mM KCl, 500 nM of primer P1 (first
30 cycles), 500 nM of primer P3 (final 5 cycles), 1 mMoughly in dH2O. Finally, sections were air-dried at 757.
PCR primers were designed to bind to gene 71 se- of primer P2, 1 U of Thermococcus litoralis (Tli) DNA
polymerase (Promega). Sections were overlaid with 10quences flanking the lacZ cassette present in ED71 (Fig.
1B). An upstream primer (P1) consisted of nucleotides ml of PCR mix and covered with coverslips. The edges
of the coverslips were then sealed with nail varnish. In90 to 110 of the coding sequence of gene 71 and a
downstream primer (P2) was designed containing the order to increase the eventual number of functional b-
galactosidase molecules, the thermostable Tli DNA poly-reverse complement of nucleotides 1940 to 1960 of gene
71 as well as two in-frame tandem stop codons to ensure merase possessing a 3* to 5* proof-reading function was
selected.efficient release of ribosomes from the mRNAs (Fig. 1C).
A third primer, P3, contained the same gene-71-specific The first 30 cycles were performed with the P1 and P2
primer set. Each cycle consisted of denaturation at 957sequences as P1 in addition to the T7 RNA polymerase
promoter and a ribosome binding site as described pre- for 1 min, annealing at 607 for 1 min, and extension at
757 for 3 min. Primer P3 was then added to the reactionviously (20), except that an ATG start codon was incorpo-
rated upstream of the gene-71-specific primer se- and a further five cycles were performed with the anneal-
ing temperature raised to 657. Finally, the temperaturequences (Fig. 1C). In order to check the correct binding of
primers to EHV-1 DNA and synthesis of b-galactosidase, was held at 757 for 5 min to complete extensions. Follow-
ing completion of the PCR reactions the coverslips weresolution PCR on ED71 and wild-type DNA using primers
P2 and P3 was carried out (30 cycles: 957, 1 min; 657, 1 removed and the sections were air-dried. To facilitate
the addition of solutions subsequently added to the sec-min; 757, 3 min) and the resultant templates were used
in in vitro transcription/translation and X-Gal reactions. tions, the lid end portions of 0.5-ml microfuge tubes were
cut 5 mm from the top using a hot scalpel blade. TheOnly DNA amplified from ED71, after in vitro transcription/
translation, was able to yield protein which converted X- edges were smoothed and the tubes were then glued
onto the microscope slides thus enclosing the sections.Gal to its chromogenic reaction product (not shown).
In situ PCR was performed using an Omnigene thermal Care was taken not to let the adhesive come into contact
with sections.cycler (Hybaid Ltd, UK). The unit was operated under
‘‘simulated slide control’’ mode which allows for correct The PCR-generated lacZ templates were then tran-
scribed/translated in situ using the E. coli S-30 extractcycling temperatures to be achieved at the top of a stan-
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FIG. 2. Sections through the olfactory bulbs of mice infected i.n. with 1 1 107 PFU of ED71. (A) A 5-mm section prepared at 5 days p.i. and reacted
with X-Gal. Blue cells (mitral/tufted neurons) indicate sites of EHV-1 infection. The tissue in B was dissected at 2 months p.i. and sectioned at 5
mm for in situ PS–PCR as detailed in the text. Following reaction with X-Gal, b-galactosidase enzyme activity may be seen to be concentrated
predominantly over neurons (arrowheads) of the mitral/tufted lineage indicating these to be sites of EHV-1 latency. An additional section prepared
from the same tissue shown in B and reacted with X-Gal without being taken through in situ PS– PCR is shown in C. There is no evidence of b-
galactosidase in this section, indicating that the b-galactosidase present in B was due to protein synthesized by in situ PS– PCR and not as a
result of virus reactivation or endogenous enzyme activity. Similarly, uninfected control tissues showed no signs of b-galactosidase activity following
in situ PS– PCR (D). All sections were counterstained with H / E.
gene expression kit for linear DNA. A 1 in 10 dilution were rinsed in PBS and counterstained with H/ E before
being mounted in DPX (BDH, Poole, Dorset, UK).of S-30 extract was made in buffer (10 mM Tris acetate,
pH 8.0, 14 mM Mg(acetate)2 , 60 mM K(acetate), 1 mM A 5-mm-thick section of olfactory bulb latently in-
fected with ED71 which has been taken through theDTT, 50 mg/ml para-toluenesulfonyl fluoride (20)) and
the ‘‘complete premix,’’ included in the kit, diluted 10- in situ PS – PCR procedure is shown in Fig. 2B. Al-
though the intensity of the chromogenic reaction prod-fold in ultrapure water. Fifteen microliters of diluted
extract was added to 20 ml of diluted premix and made uct was not as great as that seen in lytically infected
neurons (Fig. 2A), it was sufficient to identify neuronsup to 50 ml with ultrapure water. The solution was
briefly vortexed and then 10 ml was added to each as the site of latent infection. The average number of
b-galactosidase-positive neurons per olfactory bulbsection. Incubations were carried out at 377 for 30
min. Solutions and sections were preincubated at the section during lytic infection was 29 compared to 12
as determined by in situ PS– PCR after latent infection.appropriate temperature prior to addition of the solu-
tions to the sections. After completion of the protein Ninety percent of b-galactosidase-positive neurons
were situated in the mitral/tufted layer of the olfactorysynthesis reactions, the solution overlying the sec-
tions was made 4% with respect to paraformaldehyde bulb. Some positive cells were also found in the granu-
lar layer. An additional section cut from the same ol-by the addition of 10 ml of 8% ice-cold paraformalde-
hyde in PBS. The sections were then placed on ice factory bulb shown in Fig. 2B, when reacted with X-
Gal without previously being taken through in situ PS –for 15 min followed by washes in two changes of PBS.
Twenty microliters of X-Gal reaction solution (0.1% (w/ PCR, was b-galactosidase-negative indicating that
the presence of b-galactosidase was not due to spon-v) Na desoxycholate, 0.1% (v/v) NP40, 5 mM K/ ferricy-
anide, 5 mM K/ ferrocyanide, 2 mM MgCl2 in PBS) taneously reactivating virus in the tissue (Fig. 2C). No
virus could be reactivated from the other olfactory lobecontaining 0.1 mg/ml X-Gal was then added to the
sections and incubations were performed at 377 until of this same animal by explant/cocultivation. Further-
more, when in situ PS – PCR was performed on sec-the appearance of the blue reaction product. Sections
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